drugset / Trial / NCT05383521

Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas Vaginitis

NCT05383521

Unknown 20 enrolled Shangrong Fan
RandomizedSingle-groupOpen-labelTreatment

Summary

We compare two oral tinidazole regimens for refractory trichomonas vaginitis.

Timeline

Start
2025-12-01
Primary completion
2025-12-30
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject tinidazole Small molecule 1 g Oral
Subject tinidazole Small molecule 2 g Oral
Background Metronidazole Small molecule 400 mg Intravenous